Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules

References

• Chorny M, Fishbein I, Danenberg H, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release 2002; 83: 389–400
   PubMed Web of Science ®Google Scholar
• Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: a review. Critical Reviews™ in Therapeutic Drug Carrier Systems 2002; 19: 99–134
   PubMed Web of Science ®Google Scholar
• Couvreur P, Couarrazze G, Devissaguet JP, Puisieux F. Nanoparticles: preparation and characterization. Microencapsulation—methods and industrial applications, S Benita. Marcel Dekker, New York 1996; 183–211
   Google Scholar
• Donohue R, Mazzaglia A, Ravoo BJ, Darcy R. Cationic beta-cyclodextrin bilayer vesicles. Chemical Communications (Cambridge) 2002; 7: 2864–2865
   Web of Science ®Google Scholar
• Dubes A, Parrot-Lopez H, Abdelwahed W, Degobert G, Fessi H, Shahgaldian P, Coleman AW. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. European Journal of Pharmaceutics and Biopharmaceutics 2003; 55: 279–282
   PubMed Web of Science ®Google Scholar
• Duchene D, Ponchel G, Wouessidjewe D. Cyclodextrins in targeting application to nanoparticles. Advanced Drug Delivery Reviews 1999a; 36: 29–40
   PubMed Web of Science ®Google Scholar
• Duchene D, Wouessidjewe D, Ponchel G. Cyclodextrins and carrier systems. Journal of Controlled Release 1999b; 62: 263–268
   PubMed Web of Science ®Google Scholar
• Falvey P, Lim CW, Darcy R, Revermann T, Karst U, Giesbers M, Marcelis ATM, Lazar A, Coleman AW, Reinhoudt DN, Ravoo BJ. Bilayer vesicles of amphiphilc cyclodextrins: host membranes that recognize guest molecules. Chemistry European Journal 2005; 11: 1171–1180
   PubMed Web of Science ®Google Scholar
• Fessi H, Devissaguet JP, Thies C. Process for the preparation of dispersible colloidal systems of a substance in the form of nanospheres. US Patent, 5,118,529, 1988
   Google Scholar
• Geze A, Aous S, Baussanne I, Putaux JL, Defaye J, Wouessidjewe D. Influence of chemical structure of amphiphilic β-cyclodextrins on their ability to form stable nanoparticles. International Journal of Pharmaceutics 2002; 242: 301–305
   PubMed Web of Science ®Google Scholar
• Hedges AR. Industrial applications of cyclodextrins. Chemical Reviews 1998; 98: 2035–2044
   PubMed Web of Science ®Google Scholar
• Hincal AA, Memisoglu-Bilensoy E, Bochot A, Duchene D. β-cyclodextrines amphiphiles: éevaluation de nouveaux excipients pour la prèparation de nanoparticules destinées à l'administration par voie parentérale ou topique. Bulletin Technique Gattefossé 2003; 96: 35–48
   Google Scholar
• Legrand P, Barratt G, Mosqueira V, Fessi H, Devissaguet JP. Polymeric nanocapsules as drug delivery systems. STP Pharma Sciences 1999; 9: 411–418
   Google Scholar
• Lemos-Senna E, Wouessidjewe D, Lesieur S, Duchene D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsion solvent evaporation method, influence of the surfactant on preparation and hydrophobic drug loading. International Journal of Pharmaceutics 1998b; 170: 119–128
   Web of Science ®Google Scholar
• Lemos-Senna E, Wouessidjewe D, Lesieur S, Puisieux F, Couarrazze G, Duchene D. Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphlic cyclodextrin nanospheres. Pharmaceutical Development and Technology 1998a; 3: 1–10
   PubMedGoogle Scholar
• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins 1. Drug solubilization and stability. Journal of Pharmaceutical Sciences 1996; 85: 1017–1025
   Google Scholar
• Mazzaglia A, Angelini N, Darcy R, Donohue R, Lombardo D, Micali N, Sciortino MT, Villari V, Scolaro LM. Novel heterotropic colloids of anionic porphyrins entangled in cationic amphiphilic cyclodextrins: spectroscopic investigation and intracellular delivery. Chemistry European Journal 2003; 9: 5762–5769
   PubMed Web of Science ®Google Scholar
• Memisoglu E, Bochot A, Özalp M, Şen M, Duchene D, Hincal AA. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes. Pharmaceutical Research 2003a; 20: 117–125
   PubMed Web of Science ®Google Scholar
• Memisoglu E, Bochot A, Şen M, Charon D, Duchene D, Hincal AA. Amphiphilic β-cyclodextrins modified on the primary face. synthesis, characterization and evaluation of their potential as novel excipients in the preparation of nanocapsules. Journal of Pharmaceutical Sciences 2002; 91: 1214–1224
   Google Scholar
• Memisoglu E, Bochot A, Şen M, Duchene D, Hincal AA. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. International Journal of Pharmaceutics 2003b; 251: 143–153
   PubMed Web of Science ®Google Scholar
• Moffat AC, Jackson JV, Moss MS, Widdop B. Clarke's isolation and identification of drugs in pharmaceuticals, body fluids and post mortem material. London Pharmaceutical Press, London 1986
   Google Scholar
• Pitaksuteepong T, Davies NM, Tucker IG, Rades T. Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerization of water-in-oil microemulsions. European Journal of Pharmaceutics and Biopharmaceutics 2002; 53: 335–342
   PubMed Web of Science ®Google Scholar
• Rajewski RA, Stella VJ. Pharmaceutical applications of cyclodextrins.2. In vivo drug delivery. Journal of Pharmaceutical Sciences 1996; 85: 1142–1169
   PubMed Web of Science ®Google Scholar
• Ringard-Lefebvre C, Bochot A, Memisoglu E, Charon D, Duchene D, Baszkin A. Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system. Colloids and Surfaces B. Biointerfaces 2002; 25: 109–117
   Web of Science ®Google Scholar
• Skiba M, Duchene D, Puisieux F, Wouessidjewe D. Development of a new colloidal drug carrier from chemically-modified cyclodextrins: nanospheres and influence of physicochemical and technological factors on particle size. International Journal of Pharmaceutics 1996a; 129: 113–121
   Web of Science ®Google Scholar
• Skiba M, Nemati F, Puisieux F, Duchene D. Spontaneous formation of drug containing amphiphilic β-cyclodextrin nanocapsules. International Journal of Pharmaceutics 1996b; 145: 241–245
   Web of Science ®Google Scholar
• Stella VJ, Venkatramana MR, Zannou EA, Zia V. Mechanisms of drug release from cyclodextrin complexes. Advanced Drug Delivery Reviews 1999; 36: 3–16
   PubMed Web of Science ®Google Scholar
• Sukegawa T, Furuike T, Niikura K, Yamagishi A, Monde K, Nishimura S. Erythrocyte-like liposomes by means of amphiphilic cyclodextrin sulphates. Chemical Communications (Cambridge) 2002; 7: 430–431
   Web of Science ®Google Scholar
• Tchoreloff P, Boissonnade MM, Coleman AW, Baszkin A. Amphiphilic monolayers of insoluble cyclodextrins at the water/air interface. surface pressure and surface potential studies. Langmuir 1995; 11: 191–196
   Google Scholar
• Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Advanced Drug Delivery Reviews 1998; 36: 3–16
   Google Scholar
• Watnasirichaikul S, Rades T, Tucker IG, Davies NM. Effects of formulation variables on characteristics of poly(ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. International Journal of Pharmaceutics 2002; 235: 237–246
   PubMed Web of Science ®Google Scholar
• Wouessidjewe D, Skiba M, Leroy-Lechat F, Lemos-Senna E, Puisieux F, Duchene D. A new concept in drug delivery based on skirt-shaped cyclodextrin aggregates. Present state and future prospects. STP Pharma Sciences 1996; 6: 21–26
   Google Scholar